Skip to main content

JanOne Inc. (JAN)

NASDAQ: JAN · IEX Real-Time Price · USD
6.05
-0.01 (-0.17%)
After-hours:Oct 22, 2021 7:53 PM EDT
6.06
-0.21 (-3.35%)
At close: Oct 22, 4:00 PM
Market Cap17.13M
Revenue (ttm)38.69M
Net Income (ttm)-8.25M
Shares Out2.41M
EPS (ttm)-4.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume61,628
Open6.22
Previous Close6.27
Day's Range6.02 - 6.34
52-Week Range3.49 - 31.83
Beta1.56
Analystsn/a
Price Targetn/a
Est. Earnings DateNov 8, 2021

About JAN

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain. It operates in three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral art...

IndustryCommercial Services & Supplies
Founded1976
Employees172
Stock ExchangeNASDAQ
Ticker SymbolJAN
Full Company Profile

Financial Performance

In 2020, JanOne's revenue was $33.87 million, a decrease of -3.50% compared to the previous year's $35.10 million. Losses were -$8.50 million, -28.97% less than in 2019.

Financial Statements

News

JanOne Expects Revenue Push From ARCA Recycling's Appliance Replacement Contracts

JanOne Inc (NASDAQ: JAN) stated subsidiary ARCA Recycling, Inc. had seen growth in its appliance replacement programs throughout the past 12 months, with the addition of new contracts signed this year t...

3 days ago - Benzinga

ARCA Recycling, a Subsidiary of JanOne Inc., Sees Major Increase in Appliance Replacement Contracts, Estimated to Pus...

MINNEAPOLIS, Oct. 19, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), has seen major growth in its appliance replacement programs throughout the past 1...

3 days ago - PRNewsWire

ARCA Recycling, a Subsidiary of JanOne Inc., Opens Recycling Center in Michigan to Support New Multi-Year Contracts T...

MINNEAPOLIS, Oct. 12, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), recently opened a new recycling facility in Grand Rapids, Michigan to support its...

1 week ago - PRNewsWire

ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contracts in Pennsylvania With Total Estimated Value o...

MINNEAPOLIS, Oct. 7, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), was recently awarded multiple contracts to operate appliance recycling programs in...

2 weeks ago - PRNewsWire

Janone Subsidiary Opens New Recycling Center In Pennsauken, New Jersey

Janone Inc (NASDAQ: JAN), subsidiary ARCA Recycling, Inc., opened a new appliance recycling center in Pennsauken, New Jersey, to process appliances collected through new programs with multiple electric ...

3 weeks ago - Benzinga

ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling Programs

MINNEAPOLIS, Sept. 30, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), opened a new appliance recycling center last month in Pennsauken, New Jersey.

3 weeks ago - PRNewsWire

JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101

LAS VEGAS, Sept. 28, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of treatments for conditions that cause severe pain – in conjunction with its continuing fo...

3 weeks ago - PRNewsWire

JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Pati...

LAS VEGAS, July 22, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...

3 months ago - PRNewsWire

JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites

LAS VEGAS, June 23, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...

3 months ago - PRNewsWire

JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing

LAS VEGAS, June 22, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...

4 months ago - PRNewsWire

JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board

LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...

4 months ago - PRNewsWire

JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives

LAS VEGAS, June 10, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...

4 months ago - PRNewsWire

JanOne Advances Toward Initiation of Phase 2b Peripheral Artery Disease (PAD) Trial for Lead Product Candidate JAN101

LAS VEGAS, June 8, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving propertie...

4 months ago - PRNewsWire

JanOne Announces Closing of $6.0 Million Common Stock Offering

LAS VEGAS, Feb. 2, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving propertie...

8 months ago - PRNewsWire

JanOne Prices $6.0 Million Common Stock Offering

LAS VEGAS, Jan. 29, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...

8 months ago - PRNewsWire

Why JanOne's Stock Are Trading Higher Today

JanOne (NASDAQ: JAN) shares are trading higher as speculative retail trading, particularly among the Reddit community, continues to drive volatility in the stock. JanOne is focused on reducing opioid ad...

8 months ago - Benzinga

JAN Stock: JanOne Shares Skyrocket as Part of Reddit Run-Up Fever

JanOne (JAN) stock is soaring higher Thursday morning as it joins other stocks being boosted by Reddit and other social media users. The post JAN Stock: JanOne Shares Skyrocket as Part of Reddit Run-Up ...

8 months ago - InvestorPlace

JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Ar...

LAS VEGAS, Sept. 22, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving propert...

1 year ago - PRNewsWire

JanOne Announces Strategic Plan to Divest its Legacy Businesses

LAS VEGAS, Sept. 16, 2020 /PRNewswire/ -- JanOne Inc.

1 year ago - PRNewsWire

JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript

JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript

1 year ago - Seeking Alpha

JanOne to Present at The LD 500 Virtual Conference

LAS VEGAS, Aug. 19, 2020 /PRNewswire/ -- JanOne Inc.

1 year ago - PRNewsWire